(Q79324113)
Statements
Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study (English)
G Samsioe
E Boschitsch
H Concin
C De Geyter
A Ehrenborg
J Heikkinen
R Hobson
M Arguinzoniz
P Ibarra de Palacios
C Scheurer
G Schmidt
Estalis 50/140 Study Group